Commercial Business Manager North (MedTech)

Location: Leeds, West Yorkshire, United Kingdom

Company

Johnson & Johnson MedTech develops healthcare technologies, with DePuy Synthes focused on orthopaedic and neurological products, services, and programs.

What you will do

• Build long-term relationships with C-suite, regional, site-level, clinical, and non-clinical NHS stakeholders.
• Develop value-based commercial proposals and strategic partnership agreements for the orthopaedic portfolio.
• Support NHS procurement framework sign-ups, tender applications, negotiations, and contract management.
• Analyse customer, health-economic, market, and performance data to shape pricing and commercial offers.
• Manage price, volume, mix, commercial terms, framework changes, pricing reviews, and contract compliance.
• Work across value, sales, tenders, and pricing teams to deliver sustainable profitable growth.

Requirements

• 5+ years of experience in commercial operations, sales excellence, or related roles in healthcare or medical devices.
• Commercial acumen and experience working with the NHS or private healthcare sector.
• Extensive experience using data to build commercial proposals and analyse market and customer performance.
• Experience with healthcare deal-making, contract shaping, tender processes, commercial frameworks, and negotiations.
• Strong communication, presentation, interpersonal, stakeholder management, change management, and problem-solving skills.
• Proficiency in Microsoft Office, CRM systems, and data analytics tools; Salesforce and business intelligence platform experience is preferred.

Nice to have

• Experience with hospital operations, operative pathways, sustainable procurement, vendor selection, and medical device regulation.
• Experience shaping contracts outside formal procurement frameworks.

Culture & Benefits

• Inclusive work environment that values individual contribution, diversity, and dignity.
• Cross-functional collaboration across the MedTech commercial matrix.
• Employment is expected to transition to DePuy Synthes following the planned orthopaedics business separation, subject to legal and regulatory requirements.